Browsing tag:

erectile dysfunction


Recent news from a professional soccer team in Bolivia has surprised the pharmaceutical community. Spain’s El Mundo reported in March of 2015 that the River Plate soccer team, hailing from Argentina, touted the use of Sildenafil to combat altitude sickness. Sildenafil Citrate, the erectile dysfunction therapy known also as Viagra, is certainly a unique remedy[…]

Read More

The close of 2014 brought exciting news for patients suffering from dementia with the announcement that Tadalafil, a commonly used drug that treats erectile dysfunction, is being tested as a treatment for dementia. The Alzheimer’s Drug Discovery Foundation and the Alzheimer’s Society UK shared the news of their partnership and funding, which would be earmarked[…]

Read More

At the 28th Annual EAU Congress, held in mid- March 2013 some startling statistic regarding men suffering from Erectile Dysfunction were revealed. Known also as ED, Erectile Dysfunction plagues almost 88 million men worldwide.  Shocking numbers from a large clinical study of a subset of these patients, specifically a little over 6 million men, showed[…]

Read More

Tadalafil, also known as Cialis, is making headlines in pharmaceutical news. A study released on March 18, 2013 touted the use of tadalafil alongside finasteride for sizably improving scores for men on the International Prostate Symptom Score. Marketed by Eli Lilly, the patent for Cialis expires on November 21, 2017. The study, which was revealed[…]

Read More

Alprostadil, CAS# 745-65-3, is also known as the brand name Caverject, which is marketed by Pfizer. This unique injectable medication is used to treat erectile dysfunction, or ED. While some men find the method of delivery difficult, alprostadil is an essential option for many men who cannot take typical oral medications, like viagra and cialis.[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service